Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes

From Pubdrug

(List of links)
Jump to: navigation, search
< Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes

The following pages link to here:

View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500). View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500).
Views
Personal tools